NASDAQ · OSRHW
OSR Holdings, Inc.
Healthcare · Biotechnology
$0.03
Down-$0.00 (-1.00%)
Updated Sep 12, 2026, 11:54 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.28M
- P/E ratio
- -0.84
- Dividend yield
- 0.00%
- 52-week range
- $0.03 – $0.10
- Volume
- 30.12K
- Avg. volume
- 44.73K
Price performance
OSRHW price history
1M range · 8 trading sessions · Daily adjusted prices
OSRHW closed at $0.03 after 8 trading sessions, down 47.37% for the selected period.
- Last close
- $0.03
- Period change
- -47.37%
- Period low
- $0.03
- Period high
- $0.05
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | $0.0281 | $0.0282 | $0.025 | $0.025 | 30.12K |
| Aug 24, 2026 | $0.045 | $0.045 | $0.045 | $0.045 | 355 |
| Aug 21, 2026 | $0.028 | $0.0375 | $0.028 | $0.0349 | 22.84K |
| Aug 20, 2026 | $0.0276 | $0.0378 | $0.0276 | $0.0316 | 2.47K |
| Aug 19, 2026 | $0.0487 | $0.0487 | $0.0351 | $0.0482 | 12.96K |
| Aug 18, 2026 | $0.0495 | $0.0584 | $0.0356 | $0.0356 | 21.36K |
| Aug 17, 2026 | $0.0275 | $0.0498 | $0.0275 | $0.0496 | 169.59K |
| Aug 14, 2026 | $0.0478 | $0.0478 | $0.0253 | $0.0475 | 3.87K |
Latest OSRHW news
The latest Smart Investors Daily articles mentioning OSRHW.
Stock researchCompany · Overview
OSRHW research
Overview
Company profile and research snapshot.
Company profile
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
